AyuVis: Funding, Investors & Team (Sep 2026)
AyuVis is a start-up biopharmaceutical company, developing a new class of immunotherapies to prevent and treat inflammation and infection. Its focus is on the development of the New Molecular Entities (NME)/ New Technologies as immune-modulating, anti-infective, and anti-inflammatory drugs. It is developing proprietary small molecule therapeutics, which have the potential to transform the treatment prospects for patients with life-threatening respiratory conditions including bronchopulmonary dysplasia, Pseudomonas aeruginosa pneumonia, cystic fibrosis, ARDS, COPD, and other inflammatory or infectious diseases. Suchismita Acharya founded the biotech company in 2014 and is based in Fort Worth, Texas.
AyuVis has raised $3.9M across 2 funding rounds on record, the most recent an undisclosed round of $2.1M announced in May 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AyuVis Company Profile and Key Stats
Latest funding round on record: May 2023.
AyuVis Funding Rounds
AyuVis raised $1.8M in a Grant announced in May 2022.
1 years later, an undisclosed round of $2.1M was announced in May 2023.
AyuVis Founders and Leadership Team
Contact details for the AyuVis team: 2 of 2 have an email address on file.
Start 14-day free trial →AyuVis Funding Compared to Other Biotechnology Startups
AyuVis' latest round of $2.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AyuVis in Biotechnology and Fort Worth
Companies Similar to AyuVis
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
AyuVis Funding FAQs
What does AyuVis do?
AyuVis is a start-up biopharmaceutical company, developing a new class of immunotherapies to prevent and treat inflammation and infection. Its focus is on the development of the New Molecular Entities (NME)/ New Technologies as immune-modulating, anti-infective, and anti-inflammatory drugs. It is developing proprietary small molecule therapeutics, which have the potential to transform the treatment prospects for patients with life-threatening respiratory conditions including bronchopulmonary dysplasia, Pseudomonas aeruginosa pneumonia, cystic fibrosis, ARDS, COPD, and other inflammatory or infectious diseases. Suchismita Acharya founded the biotech company in 2014 and is based in Fort Worth, Texas.
How much funding has AyuVis raised?
AyuVis has raised $3.9M across 2 rounds on record. The most recent is an undisclosed round of $2.1M announced in May 2023.
When did AyuVis last raise funding?
AyuVis' most recent funding round on record is an undisclosed round of $2.1M, announced in May 2023.
Who founded AyuVis?
FundedIQ lists Gagan Acharya (Founder) at AyuVis.
Who is the CEO of AyuVis?
Suchismita Acharya is listed as CEO at AyuVis.
Where is AyuVis headquartered?
AyuVis is based in Fort Worth, Texas, United States.
How many employees does AyuVis have?
AyuVis is in the 1-10 employee band.
How does AyuVis' funding compare to other Biotechnology startups?
AyuVis' latest round of $2.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's AyuVis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AyuVis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.